sustained release and extended release tablets No Further a Mystery
In addition it discusses candidate drugs for GRDDS, strengths like improved bioavailability, and evaluation strategies like dissolution screening, floating time, and mucoadhesive toughness tests. Constraints involve instability at gastric pH and requirement of higher fluid stages for floating systems.This document discusses goals and procedures of